View of Ropeginterferon Alfa-2b Experience with Ph negative myeloproliferative neoplasm Treatment at Department of Internal Medicine –Hematology and Oncology in Brno

Return to Issue Details Ropeginterferon Alfa-2b Experience with Ph negative myeloproliferative neoplasm Treatment at Department of Internal Medicine –Hematology and Oncology in Brno Download Download PDF